Inhibition of Pancreatic Cancer by RhIL1RA-Response.
作者信息
Chiao Paul J, Ling Jianhua, Fu Jie, Lu Yu, Sun Yi-Chen
机构信息
Department of Molecular and Cellular Oncology, Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, University of Texas, Houston, Texas.
Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
出版信息
Clin Cancer Res. 2017 Jun 15;23(12):3224. doi: 10.1158/1078-0432.CCR-17-0083.
Abstract
摘要
相似文献
1
Inhibition of Pancreatic Cancer by RhIL1RA-Response.重组人白细胞介素1受体拮抗剂（RhIL1RA）应答对胰腺癌的抑制作用
Clin Cancer Res. 2017 Jun 15;23(12):3224. doi: 10.1158/1078-0432.CCR-17-0083.
2
Inhibitor of Pancreatic Cancer by RHIL1RA-Letter.
Clin Cancer Res. 2017 Jun 15;23(12):3223. doi: 10.1158/1078-0432.CCR-16-3270.
3
Interleukin-1 beta-induced nitric oxide synthase expression by rat pancreatic beta-cells: evidence for the involvement of nuclear factor kappa B in the signaling mechanism.白细胞介素-1β诱导大鼠胰腺β细胞一氧化氮合酶表达：核因子κB参与信号传导机制的证据
Endocrinology. 1995 Nov;136(11):4790-5. doi: 10.1210/endo.136.11.7588208.
4
Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis.IκBαM对组成性核因子κB活性的抑制作用可抑制肿瘤发生。
Oncogene. 2003 Mar 6;22(9):1365-70. doi: 10.1038/sj.onc.1206323.
5
Recombinant thrombomodulin suppresses tumor growth of pancreatic cancer by blocking thrombin-induced PAR1 and NF-κB activation.重组血栓调节蛋白通过阻断凝血酶诱导的PAR1和NF-κB激活来抑制胰腺癌的肿瘤生长。
Surgery. 2017 Jun;161(6):1675-1682. doi: 10.1016/j.surg.2016.12.008. Epub 2017 Jan 13.
6
NF-kappaB in pancreatic cancer.胰腺癌中的核因子κB
Int J Gastrointest Cancer. 2003;33(1):15-26. doi: 10.1385/IJGC:33:1:15.
7
Akt Signal Transduction Pathways and Nuclear Factor-kappa B (NF-κB) Transcription as a Molecular Target of Oral Tongue Squamous Cell Carcinoma (SP-C1) Using Papua's Anthill Plant ( Myrmecodia pendans ).以巴布亚蚁巢植物（Myrmecodia pendans）为分子靶点的Akt信号转导通路及核因子-κB（NF-κB）转录在口腔舌鳞状细胞癌（SP-C1）中的作用
Pak J Biol Sci. 2016;19(8-9):323-330. doi: 10.3923/pjbs.2016.323.330.
8
Hyperoside induces apoptosis and inhibits growth in pancreatic cancer via Bcl-2 family and NF-κB signaling pathway both in vitro and in vivo.金丝桃苷在体外和体内均通过Bcl-2家族和NF-κB信号通路诱导胰腺癌细胞凋亡并抑制其生长。
Tumour Biol. 2016 Jun;37(6):7345-55. doi: 10.1007/s13277-015-4552-2. Epub 2015 Dec 16.
9
Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells.姜黄素下调Notch-1与抑制胰腺癌细胞生长及诱导其凋亡有关。
Cancer. 2006 Jun 1;106(11):2503-13. doi: 10.1002/cncr.21904.
10
Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.蟾毒灵通过c-Myc/NF-κB途径诱导细胞周期停滞来抑制胰腺癌。
J Ethnopharmacol. 2016 Dec 4;193:538-545. doi: 10.1016/j.jep.2016.09.047. Epub 2016 Sep 28.
本文引用的文献
1
New treatment strategy with nuclear factor-κB inhibitor for pancreatic cancer.采用核因子-κB抑制剂治疗胰腺癌的新策略
J Surg Res. 2016 Nov;206(1):1-8. doi: 10.1016/j.jss.2016.06.047. Epub 2016 Jun 25.
2
Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade.吉西他滨治疗通过 Nox/ROS/NF-κB/STAT3 信号级联促进胰腺癌干性。
Cancer Lett. 2016 Nov 1;382(1):53-63. doi: 10.1016/j.canlet.2016.08.023. Epub 2016 Aug 26.
3
Coix seed emulsion synergistically enhances the antitumor activity of gemcitabine in pancreatic cancer through abrogation of NF-κB signaling.薏苡仁油乳剂通过消除核因子-κB信号通路协同增强吉西他滨对胰腺癌的抗肿瘤活性。
Oncol Rep. 2016 Sep;36(3):1517-25. doi: 10.3892/or.2016.4958. Epub 2016 Jul 21.
4
IL1 Receptor Antagonist Inhibits Pancreatic Cancer Growth by Abrogating NF-κB Activation.白细胞介素1受体拮抗剂通过消除核因子κB激活来抑制胰腺癌生长。
Clin Cancer Res. 2016 Mar 15;22(6):1432-44. doi: 10.1158/1078-0432.CCR-14-3382. Epub 2015 Oct 23.
Zotero 插件